Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The objective is to assess the efficacy and safety of BAY 59-7939 10 mg once daily dosing in prevention of VTE in men and women aged 18 years or above undergoing elective total knee replacement.
Inclusion criteria
- Prevention of venous thromboembolism